Patients undergoing brain tumor surgery at level 2 facilities within Mexico’s Ministry of Health system experienced higher in-hospital mortality than those treated at level 3 facilities, according to a retrospective registry study. The research evaluated national records to address how structural and geographic elements influence neurosurgical care outcomes, noting that brain neoplasms generate substantial morbidity and mortality across low- and middle-income countries while systemic access factors remain poorly quantified.
The investigation analyzed national discharge registry records spanning from 2010 through 2022, capturing data from 10,532 surgical patients treated across Ministry of Health hospitals. Investigators evaluated the relationship between facility level and in-hospital mortality alongside the effect of geographic travel duration. The team also evaluated timely access metrics across both the surgical patient cohort and the broader national population to measure geographic coverage against established global health standards.
To evaluate mortality associations, the researchers applied multivariable logistic regression models incorporating hospital-clustered standard errors. These statistical models adjusted for relevant clinical and socioeconomic covariates to isolate the potential influence of hospital designation and travel time. By accounting for institutional clustering and baseline patient characteristics, the analytical framework evaluated whether facility tiers independently correlated with patient survival during inpatient admission.
The primary statistical outcome demonstrated that undergoing surgery at a level 2 hospital versus a level 3 hospital was associated with higher in-hospital mortality, yielding an adjusted odds ratio of 1.25 with a 95 percent confidence interval spanning from 1.01 to 1.56. In sensitivity analyses, this association persisted across an odds ratio range between 1.22 and 1.40, indicating consistent elevated mortality risk for patients treated at secondary facilities compared to tertiary specialized centers.
Geographic travel time demonstrated a less consistent association with surgical mortality, showing a modest increase of four percent higher odds per hour of travel beyond two hours, supported by an odds ratio of 1.04 and a 95 percent confidence interval from 1.00 to 1.07. Among the 10,532 analyzed surgical patients, 74.4 percent managed to reach medical care within two hours of travel.
Population-level geographic analysis revealed that 68.0 percent of the overall Mexican population resided within two hours of a Ministry of Health level 3 neurosurgical center. This proportion falls substantially below the 80 percent geographic access target established by the Lancet Commission benchmarks. The finding highlights that surgical neuro-oncology resources remain geographically concentrated within the public health network.
The study identified disparities in reaching care promptly, noting that residing in an Indigenous community, pediatric age, and male sex were independently associated with lower odds of achieving timely access within the two-hour window. Furthermore, patient-level clinical characteristics showed strong relationships with survival, as malignancy, older age, and pediatric age were significantly associated with higher in-hospital mortality.
Concluding their analysis, the authors emphasized that brain tumor surgical interventions remain geographically concentrated within public facilities in Mexico. Because secondary level 2 hospitals demonstrated higher in-hospital mortality, the authors concluded that these findings warrant a formal evaluation of level 2 neurosurgical capacity alongside the systematic strengthening of referral pathways directing complex patients to specialized tertiary centers.
Subject of Research: Surgical access and in-hospital mortality for brain tumors in Mexico
Article Title: Geographic and structural factors in brain tumor surgery in Mexico: access, hospital level, and in-hospital mortality in Ministry of Health hospitals
Article References: Cure, H. W., Wurdeman, T., Reddy, R., Ortega-Porcayo, L. A., Dey, T., Golby, A. J., Park, K. B., Uribe-Leitz, T., & Moreno-Jiménez, S. (2026). Geographic and structural factors in brain tumor surgery in Mexico: access, hospital level, and in-hospital mortality in Ministry of Health hospitals. Journal of Neuro-Oncology, 180(3), Article 61. https://doi.org/10.1007/s11060-026-05881-0
Image Credits: AI Generated
DOI: 10.1007/s11060-026-05881-0
Keywords: brain tumor surgery, in-hospital mortality, Ministry of Health hospitals, Mexico, facility level, level 3 neurosurgical center, level 2 hospitals, timely access, travel time, Lancet Commission benchmark, neurosurgical care, Indigenous communities, pediatric neurosurgery, national discharge registry, multivariable logistic regression, referral pathways
News Source: Nathaniel Bowman. (November 18, 2026). Level Two Brain Tumor Surgery in Mexico Linked to Higher Mortality. Scienmag.



